In case you’re wondering, the Farm Bill is still not finished! And for most of agriculture, that’s frustrating. For the seed industry, it’s more of the same hedging. It sure feels like a very long game of Texas Hold’Em.
This is an industry built on long bets. Decisions made today won’t show up in a field for years. Yet here we are, operating under another extension of the Agriculture Improvement Act of 2018, now stretched through Sept. 30, with no clear signal on what comes next.
Yes, the House Agriculture Committee moved its version forward earlier in March. That matters. But it’s only one step. It hasn’t hit the House floor, and the Senate hasn’t shown its hand. Until both chambers align, nothing changes.
So companies are left doing what they’ve been doing for a while now — reading between the lines.
What happens to conservation programs that are quietly shaping demand for cover crops, forages and other specialty seed? Do those signals strengthen, shift or disappear? No one knows yet.
What about public breeding and research priorities? Without a new bill, there’s no real opportunity to reset where federal dollars go, even as the conversation around resilience, climate and productivity keeps evolving.
And then there’s regulation. Whether you’re working in biotech, gene editing or trait development, the absence of updated policy language leaves a lot of gray space. That’s not where you want to be when you’re making multi-year investments.
None of this stops progress. It just makes it harder to see around the corner.
